- B2B
- Public StagePublicly traded company
- Top InvestorsThis company has received a significant amount of investment from top investors
- Website
- Location
- Company size
- 51-200 people
- Total raised
- $41M
- Markets
People at Caribou Biosciences
Andy May
CSO @Caribou Biosciences , Founder @Intellia Therapeutics, Director, R&D @Fluidigm, R&D@Thios, R&D@Signature, Postdoc @Stanford, DPhil @Oxford, BA @Oxford
Chris Fuller
Life sciences VC and early-stage investor with focus and expertise in research tools and synthetic biology. Kauffman Fellow. Operational experience; startup utility player. McKinsey. PhD Genetics. BS Physics. Unafraid of category-defying opportunities.
James Berger
A
Jennifer Doudna
A